Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Net Income (2021 - 2025)

Historic Net Income for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to -$2.4 million.

  • HeartSciences' Net Income fell 1190.44% to -$2.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$9.1 million, marking a year-over-year decrease of 1701.1%. This contributed to the annual value of -$8.9 million for FY2025, which is 3293.13% down from last year.
  • HeartSciences' Net Income amounted to -$2.4 million in Q4 2025, which was down 1190.44% from -$2.1 million recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Net Income ranged from a high of -$752051.0 in Q3 2021 and a low of -$2.6 million during Q1 2025
  • In the last 5 years, HeartSciences' Net Income had a median value of -$1.8 million in 2022 and averaged -$1.7 million.
  • As far as peak fluctuations go, HeartSciences' Net Income plummeted by 10925.5% in 2022, and later surged by 2054.79% in 2023.
  • Quarter analysis of 5 years shows HeartSciences' Net Income stood at -$1.0 million in 2021, then tumbled by 74.7% to -$1.8 million in 2022, then grew by 3.28% to -$1.7 million in 2023, then fell by 20.26% to -$2.1 million in 2024, then decreased by 11.9% to -$2.4 million in 2025.
  • Its last three reported values are -$2.4 million in Q4 2025, -$2.1 million for Q3 2025, and -$2.1 million during Q2 2025.